Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.45 |
| ▸ | NPY1R | P25929 | 9/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.45 |
| ▸ | NPY2R | P49146 | 5/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | CTSD | P07339 | 2/20 | 0.42 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31514354 | 0.92 | RXFP1 (0.46) | NPY4RNPY1RNPY5RNPY2RRXFP1 | |
| SCHEMBL29416069 | 0.91 | GRIN2D (0.45) | NPY4RNPY1RNPY5RNPY2RRXFP1 | |
| SCHEMBL30085019 | 0.90 | NPY4R (0.43) | NPY4RNPY1RNPY5RNPY2RCTSD | |
| SCHEMBL30945395 | 0.89 | FURIN (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30582104 | 0.89 | FURIN (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL6389627 | 0.89 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30302888 | 0.89 | FURIN (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL6389619 | 0.89 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31110537 | 0.89 | FURIN (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29732334 | 0.89 | FURIN (0.42) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115397836-A | Novel antibacterial peptide and application thereof | 安尼根有限公司 | 2022-11-25 | — | — | CN | disclosed |